Evidence record · UDINUS · SDGs
- Unit
- Rektorat UDINUS
- Period
- 2026
- Goals
- Record
- f0d032f0-eaa1-4e89-bc0f-c01530440dc8
- Published
- 2026-10-30
Universitas Dian Nuswantoro conducted a study on the degradation of injectable bone substitute (IBS) paste scaffolds using electrical impedance spectroscopy (EIS), with researchers from UDINUS participating in the activity. The study addressed an approach involving local drug delivery using IBS paste containing streptomycin in cases of bone tuberculosis requiring immediate treatment. It investigated material degradation, drug release, and the monitoring of IBS weight change and mass loss in real time.
The activity used five polylactic acid scaffold samples with a pore size of 800 μm. The scaffolds were injected with IBS paste and immersed for different durations. The IBS paste was synthesized using a hydroxyapatite-to-gelatin ratio of 65:45. Degradation testing was conducted over a five-week period. The characterization methods included microscopic observation, degradation evaluation of the IBS paste-infused scaffolds, ultraviolet-visible (UV-Vis) analysis, and EIS measurements. The study compared EIS results with UV-Vis analysis.
Microscopic analysis showed that pore sizes ranged from 782.30 to 805.00 μm before IBS paste injection and decreased to 148.00 to 189.00 μm after injection. Degradation testing demonstrated that mass reduction of the IBS paste-infused scaffolds increased with immersion time. UV-Vis analysis indicated an upward trend in IBS paste concentration from the first week to the fifth week, increasing from 1.168% to 2.522%. The source states that a five-week release is considered sufficient to support the early stages of bone healing and graft integration. After degradation, EIS measurements correlated with a parallel RC circuit model, with R² values of 0.9325 for resistance and 0.4511 for capacitance. The activity provides documented findings on IBS scaffold degradation, drug release, and comparison of EIS with UV-Vis analysis.